Exact Mass: 468.27261480000004

Exact Mass Matches: 468.27261480000004

Found 75 metabolites which its exact mass value is equals to given mass value 468.27261480000004, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

3,17-Androstanediol glucuronide

(1S,2S,5R,7S,10R,11S,14S,15S)-14-Hydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-5-yl (2S,3S,4S,5R,6R)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid

C25H40O8 (468.272304)


3,17-Androstanediol glucuronide is a natural human metabolite of 3,17-Androstanediol generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.

   

3-alpha-Androstanediol glucuronide

(3S,5R,6S)-3,4,5-trihydroxy-6-{[(1S,2S,5R,7S,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-5-yl]oxy}oxane-2-carboxylic acid

C25H40O8 (468.272304)


3-alpha-androstanediol glucuronide is a natural human metabolite of 3-alpha-androstanediol generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.

   

17-Hydroxyandrostane-3-glucuronide

(2R,3S,4R,5R,6R)-3,4,5-trihydroxy-6-{[(1S,2S,5R,7S,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-5-yl]oxy}oxane-2-carboxylic acid

C25H40O8 (468.272304)


17-hydroxyandrostane-3-glucuronide is a natural human metabolite of 17-hydroxyandrostane generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. 17-Hydroxyandrostane-3-glucuronide is a natural human metabolite of 17-hydroxyandrostane generated in the liver by UDP glucuonyltransferase. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

3alpha-Androstanediol glucuronide

3,4,5-trihydroxy-6-[(17-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy]oxane-2-carboxylic acid

C25H40O8 (468.272304)


   

Androstanediol-17g

3,4,5-trihydroxy-6-({5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}oxy)oxane-2-carboxylic acid

C25H40O8 (468.272304)


   

DG(2:0/PGE2/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid

C25H40O8 (468.272304)


DG(2:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(PGE2/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid

C25H40O8 (468.272304)


DG(PGE2/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/PGE2)

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid

C25H40O8 (468.272304)


DG(2:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(PGE2/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid

C25H40O8 (468.272304)


DG(PGE2/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/PGD2/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoic acid

C25H40O8 (468.272304)


DG(2:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(PGD2/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoic acid

C25H40O8 (468.272304)


DG(PGD2/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/PGD2)

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoic acid

C25H40O8 (468.272304)


DG(2:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(PGD2/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoic acid

C25H40O8 (468.272304)


DG(PGD2/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

(2S)-1-(acetyloxy)-3-hydroxypropan-2-yl (5S,6S,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C25H40O8 (468.272304)


DG(2:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5R,6R,7E,9E,11Z,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C25H40O8 (468.272304)


DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

(2R)-3-(acetyloxy)-2-hydroxypropyl (5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C25H40O8 (468.272304)


DG(2:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5R,6R,7E,9E,11Z,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C25H40O8 (468.272304)


DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Gaudichaudioside A

Gaudichaudioside A

C25H40O8 (468.272304)


   

14beta-O-(2S,3R-nilyl)rhodojaponin III

14beta-O-(2S,3R-nilyl)rhodojaponin III

C25H40O8 (468.272304)


   

14beta-O-(2S,3R-nilyl)rhodomollein I

14beta-O-(2S,3R-nilyl)rhodomollein I

C25H40O8 (468.272304)


   
   

18-acetoxy-PGF2α-11-acetate methyl ester

methyl 9S,15S-dihydroxy-11R,18-diacetoxy-5Z,13E-prostadienoate

C25H40O8 (468.272304)


   

3α-androstanediol glucuronide

Androstane-3alpha,17beta-diol 3-D-glucuronide

C25H40O8 (468.272304)


   

3,17-Androstanediol glucuronide

3,17-Androstanediol glucuronide

C25H40O8 (468.272304)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

3-alpha-androstanediol glucuronide

3-alpha-androstanediol glucuronide

C25H40O8 (468.272304)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

FA 25:5;O6

methyl 9S,15S-dihydroxy-11R,18-diacetoxy-5Z,13E-prostadienoate

C25H40O8 (468.272304)


   

ST 19:0;O2;GlcA

17beta-Hydroxy-5alpha-androstan-3alpha-yl Beta-D-glucopyranosiduronic acid

C25H40O8 (468.272304)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

diethylazanide,hafnium(4+)

diethylazanide,hafnium(4+)

C16H40HfN4 (468.271841)


   

Androstanediol-17g

(3alpha,5alpha,17beta)-3-Hydroxyandrostan-17-yl D-glucopyranosiduronic acid

C25H40O8 (468.272304)


   

tetrakis(diethylamino)hafnium

tetrakis(diethylamino)hafnium

C16H40HfN4 (468.271841)


   

5alpha-Androstane-3beta,17beta-diol 17-glucuronide

5alpha-Androstane-3beta,17beta-diol 17-glucuronide

C25H40O8 (468.272304)


   

Androstane-3alpha,17beta-diol 3-delta-glucuronide

Androstane-3alpha,17beta-diol 3-delta-glucuronide

C25H40O8 (468.272304)


   

DG(2:0/PGE2/0:0)

DG(2:0/PGE2/0:0)

C25H40O8 (468.272304)


   

DG(PGE2/2:0/0:0)

DG(PGE2/2:0/0:0)

C25H40O8 (468.272304)


   

DG(2:0/0:0/PGE2)

DG(2:0/0:0/PGE2)

C25H40O8 (468.272304)


   

DG(PGE2/0:0/2:0)

DG(PGE2/0:0/2:0)

C25H40O8 (468.272304)


   

DG(2:0/PGD2/0:0)

DG(2:0/PGD2/0:0)

C25H40O8 (468.272304)


   

DG(PGD2/2:0/0:0)

DG(PGD2/2:0/0:0)

C25H40O8 (468.272304)


   

DG(2:0/0:0/PGD2)

DG(2:0/0:0/PGD2)

C25H40O8 (468.272304)


   

DG(PGD2/0:0/2:0)

DG(PGD2/0:0/2:0)

C25H40O8 (468.272304)


   

DG(2:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

DG(2:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C25H40O8 (468.272304)


   

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/2:0/0:0)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/2:0/0:0)

C25H40O8 (468.272304)


   

DG(2:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

DG(2:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C25H40O8 (468.272304)


   

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/2:0)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/2:0)

C25H40O8 (468.272304)


   

3alpha-androstanediol glucuronide

3alpha-androstanediol glucuronide

C25H40O8 (468.272304)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

2-[[(2R)-3-heptanoyloxy-2-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2R)-3-heptanoyloxy-2-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C21H43NO8P+ (468.27261480000004)


   

2-[[(2R)-2-heptanoyloxy-3-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2R)-2-heptanoyloxy-3-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C21H43NO8P+ (468.27261480000004)


   

2-[(2-Heptanoyloxy-3-hexanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(2-Heptanoyloxy-3-hexanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C21H43NO8P+ (468.27261480000004)


   

2-[(3-Acetyloxy-2-undecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(3-Acetyloxy-2-undecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C21H43NO8P+ (468.27261480000004)


   

2-[(2-Decanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(2-Decanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C21H43NO8P+ (468.27261480000004)


   

2-[Hydroxy-(2-octanoyloxy-3-pentanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-(2-octanoyloxy-3-pentanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C21H43NO8P+ (468.27261480000004)


   

2-[(3-Butanoyloxy-2-nonanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(3-Butanoyloxy-2-nonanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C21H43NO8P+ (468.27261480000004)


   

5alpha-androstane-3beta,17beta-diol 3-O-(beta-D-glucuronide)

5alpha-androstane-3beta,17beta-diol 3-O-(beta-D-glucuronide)

C25H40O8 (468.272304)


A steroid glucosiduronic acid that is 5alpha-androstane-3beta,17beta-diol having a single beta-D-glucuronic acid residue attached at position 3. It is a biochemical marker of peripheral tissue androgen metabolism.

   

17-hydroxyandrostane-3-glucuronide

17-hydroxyandrostane-3-glucuronide

C25H40O8 (468.272304)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

18-acetoxy-PGF2alpha-11-acetate methyl ester

18-acetoxy-PGF2alpha-11-acetate methyl ester

C25H40O8 (468.272304)


   
   
   

(1s,3r,4r,6r,7r,8r,10s,13r,14r,16r)-3,4,6,7,14-pentahydroxy-5,5,14-trimethyl-9-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl (2s,3s)-3-hydroxy-2-methylbutanoate

(1s,3r,4r,6r,7r,8r,10s,13r,14r,16r)-3,4,6,7,14-pentahydroxy-5,5,14-trimethyl-9-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl (2s,3s)-3-hydroxy-2-methylbutanoate

C25H40O8 (468.272304)


   

1-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-5-(hydroxymethyl)-5,8a-dimethyl-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,4,4a,6,7,8-hexahydronaphthalene-2-carbaldehyde

1-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-5-(hydroxymethyl)-5,8a-dimethyl-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,4,4a,6,7,8-hexahydronaphthalene-2-carbaldehyde

C25H40O8 (468.272304)


   

methyl (3s,5s)-7-[(1r,2r,5r,6r,8s,8ar)-5-hydroxy-2,6-dimethyl-8-[(2-methylbutanoyl)oxy]-3-oxo-2,5,6,7,8,8a-hexahydro-1h-naphthalen-1-yl]-3,5-dihydroxyheptanoate

methyl (3s,5s)-7-[(1r,2r,5r,6r,8s,8ar)-5-hydroxy-2,6-dimethyl-8-[(2-methylbutanoyl)oxy]-3-oxo-2,5,6,7,8,8a-hexahydro-1h-naphthalen-1-yl]-3,5-dihydroxyheptanoate

C25H40O8 (468.272304)


   

1-(5-hydroxy-3-methylpent-3-en-1-yl)-5-(hydroxymethyl)-5,8a-dimethyl-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,4,4a,6,7,8-hexahydronaphthalene-2-carbaldehyde

1-(5-hydroxy-3-methylpent-3-en-1-yl)-5-(hydroxymethyl)-5,8a-dimethyl-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,4,4a,6,7,8-hexahydronaphthalene-2-carbaldehyde

C25H40O8 (468.272304)


   

(4s,4ar,5s,8as)-1-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-5-(hydroxymethyl)-5,8a-dimethyl-4-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,4,4a,6,7,8-hexahydronaphthalene-2-carbaldehyde

(4s,4ar,5s,8as)-1-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-5-(hydroxymethyl)-5,8a-dimethyl-4-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,4,4a,6,7,8-hexahydronaphthalene-2-carbaldehyde

C25H40O8 (468.272304)


   

methyl (9r,10e,12s,13s,15z)-9,12,13-tris(acetyloxy)octadeca-10,15-dienoate

methyl (9r,10e,12s,13s,15z)-9,12,13-tris(acetyloxy)octadeca-10,15-dienoate

C25H40O8 (468.272304)


   

3,4,10,15-tetrahydroxy-5,5,10,15-tetramethyl-7-oxapentacyclo[12.2.1.0¹,¹¹.0⁴,⁹.0⁶,⁸]heptadecan-17-yl 3-hydroxy-2-methylbutanoate

3,4,10,15-tetrahydroxy-5,5,10,15-tetramethyl-7-oxapentacyclo[12.2.1.0¹,¹¹.0⁴,⁹.0⁶,⁸]heptadecan-17-yl 3-hydroxy-2-methylbutanoate

C25H40O8 (468.272304)


   

methyl 9,12,13-tris(acetyloxy)octadeca-10,15-dienoate

methyl 9,12,13-tris(acetyloxy)octadeca-10,15-dienoate

C25H40O8 (468.272304)


   

8-(10,11-dihydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-8-en-2-yl)-3-methoxy-4,6-dimethyl-5-oxonon-7-enoic acid

8-(10,11-dihydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-8-en-2-yl)-3-methoxy-4,6-dimethyl-5-oxonon-7-enoic acid

C25H40O8 (468.272304)


   

(2s)-2-[(1r)-1-{[(1s,5r,8as)-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methoxy}-2-butoxy-2-oxoethyl]butanedioic acid

(2s)-2-[(1r)-1-{[(1s,5r,8as)-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methoxy}-2-butoxy-2-oxoethyl]butanedioic acid

C25H40O8 (468.272304)


   

(4s,5s,8as)-1-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-5-(hydroxymethyl)-5,8a-dimethyl-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,4,4a,6,7,8-hexahydronaphthalene-2-carbaldehyde

(4s,5s,8as)-1-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-5-(hydroxymethyl)-5,8a-dimethyl-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,4,4a,6,7,8-hexahydronaphthalene-2-carbaldehyde

C25H40O8 (468.272304)


   

3,4,6,7,14-pentahydroxy-5,5,14-trimethyl-9-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl 3-hydroxy-2-methylbutanoate

3,4,6,7,14-pentahydroxy-5,5,14-trimethyl-9-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl 3-hydroxy-2-methylbutanoate

C25H40O8 (468.272304)


   

(1r,3s,4r,6s,7s,8s,10r,13s,14s,16s)-3,4,6,7,14-pentahydroxy-5,5,14-trimethyl-9-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl (2r,3s)-3-hydroxy-2-methylbutanoate

(1r,3s,4r,6s,7s,8s,10r,13s,14s,16s)-3,4,6,7,14-pentahydroxy-5,5,14-trimethyl-9-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl (2r,3s)-3-hydroxy-2-methylbutanoate

C25H40O8 (468.272304)


   

methyl 3,5-dihydroxy-7-{5-hydroxy-2,6-dimethyl-8-[(2-methylbutanoyl)oxy]-3-oxo-2,5,6,7,8,8a-hexahydro-1h-naphthalen-1-yl}heptanoate

methyl 3,5-dihydroxy-7-{5-hydroxy-2,6-dimethyl-8-[(2-methylbutanoyl)oxy]-3-oxo-2,5,6,7,8,8a-hexahydro-1h-naphthalen-1-yl}heptanoate

C25H40O8 (468.272304)


   

(1s,3r,4s,6r,8s,9s,10r,11r,14r,15r,17r)-3,4,10,15-tetrahydroxy-5,5,10,15-tetramethyl-7-oxapentacyclo[12.2.1.0¹,¹¹.0⁴,⁹.0⁶,⁸]heptadecan-17-yl (2s,3r)-3-hydroxy-2-methylbutanoate

(1s,3r,4s,6r,8s,9s,10r,11r,14r,15r,17r)-3,4,10,15-tetrahydroxy-5,5,10,15-tetramethyl-7-oxapentacyclo[12.2.1.0¹,¹¹.0⁴,⁹.0⁶,⁸]heptadecan-17-yl (2s,3r)-3-hydroxy-2-methylbutanoate

C25H40O8 (468.272304)


   

2-(2-butoxy-1-{[5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methoxy}-2-oxoethyl)butanedioic acid

2-(2-butoxy-1-{[5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methoxy}-2-oxoethyl)butanedioic acid

C25H40O8 (468.272304)


   

(3r,4r,6r,7e)-8-[(2s,3s,7r,8e,10r,11r)-10,11-dihydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-8-en-2-yl]-3-methoxy-4,6-dimethyl-5-oxonon-7-enoic acid

(3r,4r,6r,7e)-8-[(2s,3s,7r,8e,10r,11r)-10,11-dihydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-8-en-2-yl]-3-methoxy-4,6-dimethyl-5-oxonon-7-enoic acid

C25H40O8 (468.272304)